Abstract

Background: Until now, the cost of allergy treatment in the insured public health care system and the non‐insured self‐financing private health care system in Indonesia has not been well documented and published, as well as the cost of allergy treatment with subcutaneous immunotherapy. Objective: To evaluate the clinical and cost benefits of allergic rhinitis treatment in children with subcutaneous immunotherapy in a non‐insured self‐financing private health care system. Methods: A retrospective cohort study conducted from 2015 until 2020 that compared the clinical improvement and health care costs over 18 months in newly diagnosed AR children who received SCIT versus matched AR control subjects who did not receive SCIT, with each group consisting of 1098 subjects. Results: A decrease in sp‐HDM‐IgE level (kU/mL) from 20.5 + 8.75 kU/mL to 12.1 + 3.07 kU/mL was observed in the SCIT group. To reduce the symptom score of allergic rhinitis by 1.0 with SCIT, it costs IDR 21,753,062.7 per child, and for non‐SCIT, it costs IDR 104,147,878.0 per child. Meanwhile, to reduce the medication score (MS) by 1.0 with SCIT, it costs IDR 17,024,138.8, while with non‐SCIT, it costs IDR 104,147,878.0. Meanwhile, to lower combination symptoms and medication score (CSMS) by 1.0, with SCIT, it costs IDR 9,550,126.6, while with non‐SCIT, it costs IDR 52,073,938.9. Conclusions: In conclusion, this first Indonesia‐based study demonstrates substantial health care cost savings associated with SCIT for children with AR in an uninsured private health care system and provides strong evidence for the clinical benefits and cost‐savings benefits of AR treatment in children.

Original languageEnglish
Article number1841
JournalCells
Volume10
Issue number7
DOIs
Publication statusPublished - Jul 2021

Keywords

  • Allergic rhinitis
  • Clinical benefit
  • Cost‐saving benefit
  • Subcutaneous immunotherapy

Fingerprint

Dive into the research topics of 'Indonesia‐based study of the clinical and cost‐saving benefits of subcutaneous allergen immunotherapy for children with allergic rhinitis in private practice'. Together they form a unique fingerprint.

Cite this